Product Details
Treatment for disease caused by disturbances in calcium metabolism.
Treatment for disease caused by disturbances in calcium metabolism in consequence of reduced endogenous production of 1,25-dihydroxyvitamin D: Osteoporosis. Renal osteodystrophy in patients undergoing dialysis, hypoprathyroidism (post-surgical, idiopathic & pseudohypoparathyroidism), vitamin D-dependent rickets, hypophosphatemic vitamin D-resistant rickets.
Composition
Calcitriol 0.25 mcg
Dose
As directed by physician.
Indication
Postmenopausal osteoporosis, Renal osteodystrophy in patients with Chronic Renal Failure particularly those undergoing dialysis, Post-surgical hypoparthyroidism.
ABOUT THE BRAND
Established in 1982, Mega Lifesciences public company limited is actively involved in helping millions of people have access to safe, effective, world class quality nutritional & herbal supplements, OTC and ethical products.
Availability
This is a BACKORDER item.
Please take note that the waiting time for Backorder items is around 1-3 weeks from the date of payment, subject to stock availability. For orders outside Malaysia, there might be a shipment delay especially during peak holiday seasons. We will try our best to expedite all orders but in any cases that Backorder is cancelled, full cash/credit refund will be given. We sincerely appreciate your kind understanding and patience.